Soros and Drug Companies to Help Sell Health Care Reform
By Susan Brinkmann, OCDS
Staff Writer
In an effort to counter the growing opposition to Congress’ proposed health care reform, the U.S. drug industry has authorized its lobbyists to invest as much as $150 million on television commercials supporting the plan. Billionarie George Soros is also reputed to have promised $5 million toward promotion of the overhaul.
